|
Volumn 44, Issue 12, 1992, Pages 2273-2280
|
EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro
a a a b c c |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CALCIFEDIOL;
CALCITRIOL;
METHYLNITROSOUREA;
RADIOLIGAND;
SEOCALCITOL;
VITAMIN D DERIVATIVE;
VITAMIN RECEPTOR;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CANCER;
CANCER CELL CULTURE;
CANCER INHIBITION;
CELL GROWTH;
CONTROLLED STUDY;
DRUG RECEPTOR BINDING;
FEMALE;
HUMAN;
HUMAN CELL;
HYPERCALCEMIA;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RAT;
ANIMAL;
ANTINEOPLASTIC AGENTS;
CALCITRIOL;
CALCIUM;
CELL DIVISION;
COMPARATIVE STUDY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
MAMMARY NEOPLASMS, EXPERIMENTAL;
RATS;
RATS, WISTAR;
SUPPORT, NON-U.S. GOV'T;
TUMOR CELLS, CULTURED;
VITAMIN D;
|
EID: 0026619579
PISSN: 00062952
EISSN: None
Source Type: Journal
DOI: 10.1016/0006-2952(92)90669-A Document Type: Article |
Times cited : (234)
|
References (43)
|